KNSA icon

Kiniksa Pharmaceuticals

104 hedge funds and large institutions have $437M invested in Kiniksa Pharmaceuticals in 2020 Q3 according to their latest regulatory filings, with 23 funds opening new positions, 55 increasing their positions, 15 reducing their positions, and 14 closing their positions.

Holders
104
Holders Change
+8
Holders Change %
+8.33%
% of All Funds
2.1%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
23
Increased
55
Reduced
15
Closed
14
Calls
$1.49M
Puts
$1.28M
Net Calls
+$214K
Net Calls Change
+$20K
Name Market Value Shares Shares
Change
Shares
Change %
BBL
101
Beck Bode LLC
Massachusetts
$5K 300 +300 New
Carson Wealth (CWM LLC)
102
Carson Wealth (CWM LLC)
Nebraska
$1K 55
EP
103
Eversept Partners
New York
-81,700 Closed
Invesco
104
Invesco
Georgia
-50,074 Closed
GTC
105
Ghost Tree Capital
New York
-50,000 Closed
Bessemer Group
106
Bessemer Group
New Jersey
-45,800 Closed
Qube Research & Technologies (QRT)
107
Qube Research & Technologies (QRT)
United Kingdom
-20,221 Closed
SSA
108
Schonfeld Strategic Advisors
New York
-15,900 Closed
ZIM
109
Zacks Investment Management
Illinois
-14,239 Closed
Acadian Asset Management
110
Acadian Asset Management
Massachusetts
-14,021 Closed
Voloridge Investment Management
111
Voloridge Investment Management
Florida
-12,036 Closed
NFC
112
Northeast Financial Consultants
Connecticut
-8,290 Closed
PHK
113
Point72 Hong Kong
Hong Kong
-2,680 Closed
HFM
114
Harvest Fund Management
China
-1,903 Closed
FC
115
FORA Capital
Florida
-1,025 Closed
EI
116
Ellevest Inc
New York
-6 Closed
SM
117
SG3 Management
Puerto Rico
OSAM
118
O'Shaughnessy Asset Management
Connecticut
$0 19
CFGS
119
Concourse Financial Group Securities
Alabama
CG
120
Cutler Group
California
PCS
121
Personal CFO Solutions
New Jersey
$0 21,700 +2,000 +10%